Table 1.
Relationship between MNX1-AS1 expression and clinical features of patients with NSCLC
Clinical features | n | MNX1-AS1 | p | ||
---|---|---|---|---|---|
Low expression | High expression | ||||
Gender | Male | 70 | 38 | 32 | 0.255 |
Female | 46 | 20 | 26 | ||
Age | ≤50 | 41 | 21 | 20 | 0.846 |
>50 | 75 | 37 | 38 | ||
Tumor size | ≤3 cm | 54 | 22 | 32 | 0.063 |
>3 cm | 62 | 36 | 26 | ||
Pathological type | Squamous cell carcinoma | 53 | 29 | 24 | 0.351 |
Adenocarcinoma | 63 | 29 | 34 | ||
Differentiation | High | 22 | 12 | 10 | 0.641 |
Medium | 27 | 15 | 12 | ||
Low | 67 | 31 | 36 | ||
TNM stage | Ⅰ+Ⅱ | 38 | 26 | 12 | 0.006 |
Ⅲ+Ⅳ | 78 | 32 | 46 | ||
Lymph node metastasis | No | 41 | 34 | 7 | 0.000 |
Yes | 75 | 24 | 51 |